Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease

Lu Yu, Zhu Li, Rongrong Yang, Guangwei Pan, Qi Cheng, Yuanyuan He, Yijia Liu, Fanfan Liu, Mei Ma, Tong Yang, Yang Wang, Jinyu Su, Yanchao Zheng, Shan Gao, Qiang Xu, Lin Li, Chunquan Yu, Lu Yu, Zhu Li, Rongrong Yang, Guangwei Pan, Qi Cheng, Yuanyuan He, Yijia Liu, Fanfan Liu, Mei Ma, Tong Yang, Yang Wang, Jinyu Su, Yanchao Zheng, Shan Gao, Qiang Xu, Lin Li, Chunquan Yu

Abstract

Context: Thyroid hormones influence glucose homeostasis through central and peripheral regulation. To date, the association between thyroid hormone sensitivity and elevated blood glucose (EBG) in patients with coronary heart disease (CHD) remains unknown. The purpose of this study was to investigate the association between thyroid hormone sensitivity and risk of EBG in patients with CHD, and to further explore their association in different sexes and ages.

Methods: This large multicenter retrospective study included 30,244 patients with CHD (aged 30-80 years) between 1 January 2014 and 30 September 2020. Parameters representing central and peripheral sensitivity to thyroid hormones were calculated. Central sensitivity to thyroid hormones was assessed by calculating the Thyroid Feedback Quantile-based Index (TFQI), Thyroid-stimulating Hormone Index (TSHI), and Thyrotropin Thyroxine Resistance Index (TT4RI), and Parametric Thyroid Feedback Quantile-based Index (PTFQI); peripheral sensitivity to thyroid hormones was evaluated using the ratio of free triiodothyronine (FT3) /free thyroxine (FT4). Taking normal glucose tolerance (NGT) as a reference, logistic regression was used to analyse the relationship between central and peripheral thyroid hormone sensitivity and EBG in patients with CHD.

Results: Among the 30,244 participants, 15,493 (51.23%) had EBG. The risk of EBG was negatively correlated with TSHI (OR: 0.91; 95%CI: 0.91 to 0.92; P < 0.001), TT4RI (OR: 0.99; 95% CI: 0.99 to 0.99; P<0.001), TFQI (OR: 0.82; 95%CI: 0.80 to 0.84; P <0.001) and PTFQI (OR: 0.76; 95%CI: 0.74 to 0.78; P<0.001). Compared to males and patients aged 60 and below, the OR value for EBG was lower in females and in patients aged over 60 years old. Conversely, EBG risk was positively associated with FT3/FT4 (OR: 1.08; 95% CI: 1.07 to 1.09; P <0.001) and in the sex-categorized subgroups, males had higher OR values than females.

Conclusions: This study showed that thyroid hormone sensitivity is significantly associated with EBG in patients with CHD. This association is higher in females than in males, and the association in those aged over 60 years old is higher than that in patients aged 60 years and below.

Trial registration: ClinicalTrials.gov NCT04026724.

Keywords: coronary heart disease; diabetes; elevated blood glucose; prediabetes; resistance to thyroid hormones; thyroid hormone sensitivity.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Yu, Li, Yang, Pan, Cheng, He, Liu, Liu, Ma, Yang, Wang, Su, Zheng, Gao, Xu, Li and Yu.

Figures

Graphical Abstract
Graphical Abstract
Images are from Biorender.com.
Figure 1
Figure 1
Flowchart of patient recruitment.

References

    1. WHO . Cardiovascular Diseases (2022). Available at: .
    1. Xing DM, Zhu MJ, Liu CX, Wang H. Outcome Measures in Clinical Trials of Traditional Chinese Medicine for Stable Angina Pectoris. Acupunct Herb Med (2021) 1(2):99–106. doi: 10.1097/HM9.0000000000000014
    1. Ohman EM. CLINICAL PRACTICE. Chronic Stable Angina. N Engl J Med (2016) 374(12):1167–76. doi: 10.1056/NEJMcp1502240
    1. Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The Epidemic of the 20(Th) Century: Coronary Heart Disease. Am J Med (2014) 127(9):807–12. doi: 10.1016/j.amjmed.2014.04.015
    1. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. . Thyroid Studies Collaboration. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA (2010) 304(12):1365–74. doi: 10.1001/jama.2010.1361
    1. Onat A, Aydın M, Can G, Çelik E, Altay S, Karagöz A, et al. . Normal Thyroid-Stimulating Hormone Levels, Autoimmune Activation, and Coronary Heart Disease Risk. Endocrine (2015) 48(1):218–26. doi: 10.1007/s12020-014-0269-z
    1. Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical Thyroid Dysfunction and Cardiovascular Diseases: 2016 Update. Eur Heart J (2018) 39(7):503–7. doi: 10.1093/eurheartj/ehx050
    1. Wang WY, Tang YD, Yang M, Cui C, Mu M, Qian J, et al. . Free Triiodothyronine Level Indicates the Degree of Myocardial Injury in Patients With Acute ST-Elevation Myocardial Infarction. Chin Med J (Engl) (2013) 126(20):3926–9. doi: 10.3760/cma.j.issn.0366-6999.20130087
    1. Miura S, Iitaka M, Suzuki S, Fukasawa N, Kitahama S, Kawakami Y, et al. . Decrease in Serum Levels of Thyroid Hormone in Patients With Coronary Heart Disease. Endocr J (1996) 43(6):657–63. doi: 10.1507/endocrj.43.657
    1. Völz S, Svedlund S, Andersson B, Li-Ming G, Rundqvist B. Coronary Flow Reserve in Patients With Resistant Hypertension. Clin Res Cardiol (2017) 106(2):151–7. doi: 10.1007/s00392-016-1043-4
    1. Tripolt NJ, Aberer F, Riedl R, Hutz B, Url J, Dimsity G, et al. . The Effects of Linagliptin on Endothelial Function and Global Arginine Bioavailability Ratio in Coronary Artery Disease Patients With Early Diabetes: Study Protocol for a Randomized Controlled Trial. Trials (2016) 17(1):495. doi: 10.1186/s13063-016-1627-3
    1. Ida S, Kaneko R, Imataka K, Murata K. Relationship Between Frailty and Mortality, Hospitalization, and Cardiovascular Diseases in Diabetes: A Systematic Review and Meta-Analysis. Cardiovasc Diabetol (2019) 18(1):81. doi: 10.1186/s12933-019-0885-2
    1. Younis A, Younis A, Tzur B, Peled Y, Shlomo N, Goldenberg I, et al. . Metabolic Syndrome Is Independently Associated With Increased 20-Year Mortality in Patients With Stable Coronary Artery Disease. Cardiovasc Diabetol (2016) 15(1):149. doi: 10.1186/s12933-016-0466-6
    1. Younis A, Goldkorn R, Goldenberg I, Geva D, Tzur B, Mazu A, et al. . Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease. J Am Heart Assoc (2017) 6(11):e006609. doi: 10.1161/JAHA.117.006609
    1. Gronich N, Deftereos SN, Lavi I, Persidis AS, Abernethy DR, Rennert G. Hypothyroidism Is a Risk Factor for New-Onset Diabetes: A Cohort Study. Diabetes Care (2015) 38(9):1657–64. doi: 10.2337/dc14-2515
    1. Jun JE, Jee JH, Bae JC, Jin SM, Hur KY, Lee MK, et al. . Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study. Thyroid (2017) 27(1):29–38. doi: 10.1089/thy.2016.0171
    1. de Vries TI, Kappelle LJ, van der Graaf Y, de Valk HW, de Borst GJ, Nathoe HM, et al. . Thyroid-Stimulating Hormone Levels in the Normal Range and Incident Type 2 Diabetes Mellitus. Acta Diabetol (2019) 56(4):431–40. doi: 10.1007/s00592-018-1231-y
    1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. . China National Diabetes and Metabolic Disorders Study Group. Prevalence of Diabetes Among Males and Females in China. N Engl J Med (2010) 362(12):1090–101. doi: 10.1056/NEJMoa0908292
    1. Tian H, Song G, Xie H, Zhang H, Tuomilehto J, Hu G. Prevalence of Diabetes and Impaired Fasting Glucose Among 769,792 Rural Chinese Adults. Diabetes Res Clin Pract (2009) 84(3):273–8. doi: 10.1016/j.diabres.2009.03.015
    1. Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev (2019) 40(3):789–824. doi: 10.1210/er.2018-00163
    1. Li Z, Cheng Q, Liu Y, Cheng X, Wang S, He Y, et al. . Low-/High-Density Lipoprotein Cholesterol Ratio and Carotid Plaques in Patients With Coronary Heart Disease: A Chinese Cohort Study. Lipids Health Dis (2021) 20(1):144. doi: 10.1186/s12944-021-01575-w
    1. Lenfant C, Chobanian AV, Jones DW, Roccella EJ, Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): Resetting the Hypertension Sails. Hypertension (2003) 41(6):1178–9. doi: 10.1161/
    1. Liu B, Wang Z, Fu J, Guan H, Lyu Z, Wang W. Sensitivity to Thyroid Hormones and Risk of Prediabetes: A Cross-Sectional Study. Front Endocrinol (Lausanne) (2021) 12:657114. doi: 10.3389/fendo.2021.657114
    1. American Diabetes Association . 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes-2021. Diabetes Care (2021) 44(Suppl 1):S15–33. doi: 10.2337/dc21-S002
    1. Ongosi AN, Wilunda C, Musumari PM, Techasrivichien T, Wang CW, Ono-Kihara M, et al. . Prevalence and Risk Factors of Elevated Blood Pressure and Elevated Blood Glucose Among Residents of Kajiado County, Kenya: A Population-Based Cross-Sectional Survey. Int J Environ Res Public Health (2020) 17(19):6957. doi: 10.3390/ijerph17196957
    1. Fu L, Deng H, Lin WD, He SF, Liu FZ, Liu Y, et al. . Association Between Elevated Blood Glucose Level and Non-Valvular Atrial Fibrillation: A Report From the Guangzhou Heart Study. BMC Cardiovasc Disord (2019) 19(1):270. doi: 10.1186/s12872-019-1253-6
    1. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U, et al. . TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients: Differences Between Euthyroid, Untreated Hypothyroid, and Euthyroid on L-T4 Therapy Patients. Diabetes Care (2009) 32(9):1589–90. doi: 10.2337/dc09-0273
    1. Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S. Resistance to Thyroid Hormone Caused by Two Mutant Thyroid Hormone Receptors Beta, R243Q and R243W, With Marked Impairment of Function That Cannot Be Explained by Altered In Vitro 3,5,3'-Triiodothyroinine Binding Affinity. J Clin Endocrinol Metab (1997) 82(5):1608–14. doi: 10.1210/jcem.82.5.3945
    1. Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P, et al. . Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome. Diabetes Care (2019) 42(2):303–10. doi: 10.2337/dc18-1410
    1. Henareh L, Agewall S. 2-H Postchallenge Plasma Glucose Predicts Cardiovascular Events in Patients With Myocardial Infarction Without Known Diabetes Mellitus. Cardiovasc Diabetol (2012) 11:93. doi: 10.1186/1475-2840-11-93
    1. Ertugrul O, Ahmet U, Asim E, Gulcin HE, Burak A, Murat A, et al. . Prevalence of Subclinical Hypothyroidism Among Patients With Acute Myocardial Infarction. ISRN Endocrinol (2011) 2011:810251. doi: 10.1186/1475-2840-11-93
    1. Chaker L, Ligthart S, Korevaar TI, Hofman A, Franco OH, Peeters RP, et al. . Thyroid Function and Risk of Type 2 Diabetes: A Population-Based Prospective Cohort Study. BMC Med (2016) 14(1):150. doi: 10.1186/s12916-016-0693-4
    1. Chaker L, Cappola AR, Mooijaart SP, Peeters RP. Clinical Aspects of Thyroid Function During Ageing. Lancet Diabetes Endocrinol (2018) 6(9):733–42. doi: 10.1016/S2213-8587(18)30028-7
    1. Taneichi H, Sasai T, Ohara M, Honma H, Nagasawa K, Takahashi T, et al. . Higher Serum Free Triiodothyronine Levels Within the Normal Range are Associated With Metabolic Syndrome Components in Type 2 Diabetic Subjects With Euthyroidism. Tohoku J Exp Med (2011) 224(3):173–8. doi: 10.1620/tjem.224.173
    1. Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, et al. . The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects. J Clin Endocrinol Metab (2017) 102(2):434–42. doi: 10.1210/jc.2016-2965
    1. Jostel A, Ryder WD, Shalet SM. The Use of Thyroid Function Tests in the Diagnosis of Hypopituitarism: Definition and Evaluation of the TSH Index. Clin Endocrinol (Oxf) (2009) 71(4):529–34. doi: 10.1111/j.1365-2265.2009.03534.x
    1. Park SY, Park SE, Jung SW, Jin HS, Park IB, Ahn SV, et al. . Free Triiodothyronine/Free Thyroxine Ratio Rather Than Thyrotropin Is More Associated With Metabolic Parameters in Healthy Euthyroid Adult Subjects. Clin Endocrinol (Oxf) (2017) 87(1):87–96. doi: 10.1111/cen.13345
    1. Roef GL, Rietzschel ER, Van Daele CM, Taes YE, De Buyzere ML, Gillebert TC, et al. . Triiodothyronine and Free Thyroxine Levels are Differentially Associated With Metabolic Profile and Adiposity-Related Cardiovascular Risk Markers in Euthyroid Middle-Aged Subjects. Thyroid (2014) 24(2):223–31. doi: 10.1089/thy.2013.0314
    1. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Panagiotakos DB, et al. . Insulin Action in Adipose Tissue and Muscle in Hypothyroidism. J Clin Endocrinol Metab (2006) 91(12):4930–7. doi: 10.1210/jc.2006-0478
    1. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, et al. . Studies of Insulin Resistance in Patients With Clinical and Subclinical Hypothyroidism. Eur J Endocrinol (2009) 160(5):785–90. doi: 10.1530/EJE-08-0797
    1. Jansen MS, Cook GA, Song S, Park EA. Thyroid Hormone Regulates Carnitine Palmitoyltransferase Ialpha Gene Expression Through Elements in the Promoter and First Intron. J Biol Chem (2000) 275(45):34989–97. doi: 10.1074/jbc.M001752200
    1. Yang N, Yao Z, Miao L, Liu J, Gao X, Fan H, et al. . Novel Clinical Evidence of an Association Between Homocysteine and Insulin Resistance in Patients With Hypothyroidism or Subclinical Hypothyroidism. PloS One (2015) 10(5):e0125922. doi: 10.1371/journal.pone.0125922
    1. Jun JE, Jin SM, Jee JH, Bae JC, Hur KY, Lee MK, et al. . TSH Increment and the Risk of Incident Type 2 Diabetes Mellitus in Euthyroid Subjects. Endocrine (2017) 55(3):944–53. doi: 10.1007/s12020-016-1221-1
    1. Duntas LH, Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid (2013) 23(6):646–53. doi: 10.1089/thy.2011.0499
    1. Denroche HC, Huynh FK, Kieffer TJ. The Role of Leptin in Glucose Homeostasis. J Diabetes Investig (2012) 3(2):115–29. doi: 10.1111/j.2040-1124.2012.00203.x
    1. Chiu FH, Chuang CH, Li WC, Weng YM, Fann WC, Lo HY, et al. . The Association of Leptin and C-Reactive Protein With the Cardiovascular Risk Factors and Metabolic Syndrome Score in Taiwanese Adults. Cardiovasc Diabetol (2012) 11:40. doi: 10.1186/1475-2840-11-40
    1. Wang Y, Sun F, Wu P, Huang Y, Ye Y, Yang X, et al. . A Prospective Study of Early-Pregnancy Thyroid Markers, Lipid Species, and Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab (2022) 107(2):e804–14. doi: 10.1210/clinem/dgab637
    1. Qin K, Zhang F, Wu Q, Liu Z, Huang Y, Tan J, et al. . Thyroid Hormone Changes in Euthyroid Patients With Diabetes. Diabetes Metab Syndr Obes (2020) 13:2533–40. doi: 10.2147/DMSO.S260039
    1. Rawal S, Tsai MY, Hinkle SN, Zhu Y, Bao W, Lin Y, et al. . A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes. J Clin Endocrinol Metab (2018) 103(7):2447–56. doi: 10.1210/jc.2017-02442
    1. Köhrle J. Thyroid Hormone Transporters in Health and Disease: Advances in Thyroid Hormone Deiodination. Best Pract Res Clin Endocrinol Metab (2007) 21(2):173–91. doi: 10.1016/j.beem.2007.04.001
    1. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, et al. . Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling. Endocr Rev (2008) 29(7):898–938. doi: 10.1210/er.2008-0019
    1. Porcu E, Medici M, Pistis G, Volpato CB, Wilson SG, Cappola AR, et al. . A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function. PloS Genet (2013) 9(2):e1003266. doi: 10.1371/journal.pgen.1003266
    1. Krag MØ, Hasselbalch L, Siersma V, Nielsen AB, Reventlow S, Malterud K, et al. . The Impact of Gender on the Long-Term Morbidity and Mortality of Patients With Type 2 Diabetes Receiving Structured Personal Care: A 13 Year Follow-Up Study. Diabetologia (2016) 59(2):275–85. doi: 10.1007/s00125-015-3804-4
    1. Cho GJ, Lee JH, Park HT, Shin JH, Hong SC, Kim T, et al. . Postmenopausal Status According to Years Since Menopause as an Independent Risk Factor for the Metabolic Syndrome. Menopause (2008) 15(3):524–9. doi: 10.1097/gme.0b013e3181559860
    1. Boucai L, Hollowell JG, Surks MI. An Approach for Development of Age-, Gender-, and Ethnicity-Specific Thyrotropin Reference Limits. Thyroid (2011) 21(1):5–11. doi: 10.1089/thy.2010.0092
    1. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocr Rev (2013) 34(3):309–38. doi: 10.1210/er.2012-1055

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel